Revision: June 18, 2025, 9:40 a.m.
June 17, 2025
2025-2809-CofC
09/05
Committee of Conference Report on HB 377-FN, relative to health care professionals administering hormone treatments and puberty blockers.
Recommendation:
That the House recede from its position of nonconcurrence with the Senate amendment, and concur with the Senate amendment, and
That the Senate and House adopt the following new amendment to the bill as amended by the Senate, and pass the bill as so amended:
Amend RSA 332-N:2, III as inserted by section 2 of the bill by replacing it with the following:
III. Nothing in this chapter shall prohibit a health care provider from continuing the direction or administration of medication or treatment that began prior to January 1, 2026, and such continued treatment shall not be considered a violation of this chapter.
The signatures below attest to the authenticity of this Report on HB 377-FN, relative to health care professionals administering hormone treatments and puberty blockers.
Conferees on the Part of the Senate Conferees on the Part of the House
_________________________________________ _______________________________________
Sen. Rochefort, Dist. 1 Rep. W. MacDonald, Rock. 16
_________________________________________ _______________________________________
Sen. Ricciardi, Dist. 9 Rep. S. Smith, Sull. 3
_________________________________________ _______________________________________
Sen. Abbas, Dist. 22 Rep. Kofalt, Hills. 32
_______________________________________
Rep. Drew, Hills. 19